NCT07548151Completed
Guided Needle Insertion for Vascular Access
Ultrasound-Guided Power-Assisted Needle Insertion for Vascular Access Study
Source: ClinicalTrials.gov · Last updated 29 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to determine whether the study device can assist the cannulator with placing two needles during cannulation required to initiate dialysis treatment. Males or females with end-stage kidney disease who are 18 and older and not pregnant or breastfeeding can be included in the study. The main question it aims to answer is: Can the study device guide the cannulator to the arteriovenous fistula (AVF) or arteriovenous graft (AVG) and assist the cannulator with needle insertion into the AVF or AVG for dialysis cannulation?
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 14 Apr 2026
- Start date
- 14 Apr 2026
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- X9, Inc.
- Diseases
- Chronic kidney disease
- NCT number
- NCT07548151
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 14 Apr 2026 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of known (pseudo-)aneurysms, stenosis, thrombosis or stents in the AVF/AVG access site
- Presence of a condition or impediment that may interfere with ultrasound imaging
Who the study is looking for
- Males or non-pregnant, non-breastfeeding females ≥ 18 years of age
- Presence of an AVG/AVF access site in the forearm or upper arm
- AVF is actively used for dialysis treatment
- AVF diameter is between 8 mm and 12mm, confirmed by ultrasound
- AVF is ≤6 mm below the surface of the skin, confirmed by ultrasound
- Able to report their pain using a validated pain scale.
- Able and willing to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Site 1 Coordinator of this site? Confirm its status | Tashkent | Uzbekistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.